文献速递胃肠动力与功能性疾病

益生菌长双歧杆菌NCC3001降低抑郁评分并改变脑活动:一项肠易激综合征患者的先导研究

Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
PubMed 文献 · Gastroenterology · 2017-05-05

这项在加拿大麦克马斯特大学开展的双盲随机安慰剂对照先导研究纳入44例伴有轻中度焦虑和/或抑郁的腹泻型或混合型肠易激综合征成人,每日给予长双歧杆菌NCC3001或安慰剂共6周。第6周时益生菌组抑郁评分降低≥2分者14/22例,安慰剂组7/22例(P = .04),焦虑和肠易激综合征症状无显著影响,生活质量评分平均升高,功能磁共振显示对负性情绪刺激的脑区反应减弱。

要点

  • 长双歧杆菌NCC3001组第6周抑郁评分降低≥2分者14/22例,安慰剂组7/22例(P = .04)。
  • 该益生菌对焦虑和肠易激综合征症状无显著影响。
  • 益生菌组生活质量评分较安慰剂组平均升高,且对负性情绪刺激的杏仁核及额边缘区反应减弱。

核心结论

  • 在安慰剂对照试验中,益生菌长双歧杆菌NCC3001降低肠易激综合征患者的抑郁评分但不降低焦虑评分,并提高生活质量。
  • 这些改善与脑激活模式改变相关,提示该益生菌降低边缘系统反应性。

研究设计与样本

  • 随机、双盲、安慰剂对照先导研究,于2011年3月至2014年5月在加拿大麦克马斯特大学开展。
  • 纳入44例符合Rome III标准的腹泻型或混合型肠易激综合征成人,且医院焦虑抑郁量表评定为轻中度焦虑和/或抑郁。
  • 患者随机分为长双歧杆菌NCC3001组(n = 22)或安慰剂组(n = 22),每日服用共6周。
  • 第0、6、10周用经验证问卷评估焦虑抑郁、肠易激综合征症状、生活质量和躯体化;第0、6周采集粪便、尿液和血样并完成功能磁共振成像检查。

主要发现

  • 第6周时,长双歧杆菌NCC3001组22例中14例医院焦虑抑郁量表抑郁评分降低≥2分,安慰剂组22例中7例(P = .04)。
  • 长双歧杆菌NCC3001对焦虑或肠易激综合征症状无显著影响。
  • 长双歧杆菌NCC3001组生活质量评分较安慰剂组平均升高。
  • 功能磁共振分析显示,与安慰剂相比,长双歧杆菌NCC3001降低多个脑区对负性情绪刺激的反应,包括杏仁核和额边缘区。
  • 两组粪便微生物群谱、血清炎症标志物、神经营养因子和神经递质水平相似,但长双歧杆菌NCC3001组尿中甲胺类和芳香族氨基酸代谢物水平降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Probiotics can reduce symptoms of irritable bowel syndrome (IBS), but little is known about their effects on psychiatric comorbidities. We performed a prospective study to evaluate the effects of Bifidobacterium longum NCC3001 (BL) on anxiety and depression in patients with IBS. METHODS: We performed a randomized, double-blind, placebo-controlled study of 44 adults with IBS and diarrhea or a mixed-stool pattern (based on Rome III criteria) and mild to moderate anxiety and/or depression (based on the Hospital Anxiety and Depression scale) at McMaster University in Canada, from March 2011 to May 2014. At the screening visit, clinical history and symptoms were assessed and blood samples were collected. Patients were then randomly assigned to groups and given daily BL (n = 22) or placebo (n = 22) for 6 weeks. At weeks 0, 6, and 10, we determined patients' levels of anxiety and depression, IBS symptoms, quality of life, and somatization using validated questionnaires. At weeks 0 and 6, stool, urine and blood samples were collected, and functional magnetic resonance imaging (fMRI) test was performed. We assessed brain activation patterns, fecal microbiota, urine metabolome profiles, serum markers of inflammation, neurotransmitters, and neurotrophin levels. RESULTS: At week 6, 14 of 22 patients in the BL group had reduction in depression scores of 2 points or more on the Hospital Anxiety and Depression scale, vs 7 of 22 patients in the placebo group (P = .04). BL had no significant effect on anxiety or IBS symptoms. Patients in the BL group had a mean increase in quality of life score compared with the placebo group. The fMRI analysis showed that BL reduced responses to negative emotional stimuli in multiple brain areas, including amygdala and fronto-limbic regions, compared with placebo. The groups had similar fecal microbiota profiles, serum markers of inflammation, and levels of neurotrophins and neurotransmitters, but the BL group had reduced urine levels of methylamines and aromatic amino acids metabolites. At week 10, depression scores were reduced in patients given BL vs placebo. CONCLUSION: In a placebo-controlled trial, we found that the probiotic BL reduces depression but not anxiety scores and increases quality of life in patients with IBS. These improvements were associated with changes in brain activation patterns that indicate that this probiotic reduces limbic reactivity. ClinicalTrials.gov no. NCT01276626.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Pinto-Sanchez MI, Hall GB, Ghajar K, et al. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology. 2017. PMID: 28483500. doi:10.1053/j.gastro.2017.05.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。